San Diego-based mostly Viking Therapeutics marked by itself as a serious competitor while in the weight loss drug market place in February immediately after revealing promising data from the mid-phase demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when presented to be a weekly injection As well a